Clinical Trial Update: GM-CSF in Treating Patients With Relapsed Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GM-CSF in patients with relapsed prostate cancer. Results have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09